A sustainable approach for the degradation kinetics study and stability assay of the SARS-CoV-2 oral antiviral drug Molnupiravir

Molnupiravir (MPV) is the first direct-acting oral antiviral drug that effectively decreases nasopharyngeal infections with SARS-CoV-2 virus. The stability of MPV was tested by subjecting the drug to various stress conditions. The drug is liable to oxidative, acidic, and alkaline degradation and sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Edrees, Fadwa H., Draz, Mohammed E., Saad, Ahmed S., Hammad, Sherif F., Mohamed, Heba M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230467/
https://www.ncbi.nlm.nih.gov/pubmed/37258556
http://dx.doi.org/10.1038/s41598-023-34537-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230467/
https://www.ncbi.nlm.nih.gov/pubmed/37258556
http://dx.doi.org/10.1038/s41598-023-34537-6

Ejemplares similares